Dara Ajay, Sangamwar Abhay T
Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab 160062, India.
Recent Pat Anticancer Drug Discov. 2015;10(2):163-9. doi: 10.2174/1574892810666150309160344.
The article reported an in-depth comparative technology analysis of 1708 Anti-cancer patents from top 20 international universities and leading 10 Indian public funded organization and research institutes. The study segregated pioneer universities vs. technologies used in the field of Anticancer research at a level of drug discovery, development, diagnosis and treatment, which are illustrated in the form of novel substantive patent landscape maps. The reported competitive intelligent maps identified genetics, composition and synthetic compounds as dominating technologies; followed by natural extracts, combination and drug delivery systems as upcoming technologies. The least number of patents were reported by surgical apparatus, targeted therapy and animal models. In addition, the study analysed the key technologies followed by Indian universities in comparison to the international universities, to identify the overlooked technologies by the Indian public funded institutes. In an ever changing competitive world, it is essential for every university to have their own research plan and thrust areas; but at the same time, it is equally important for any organisation to have an idea of their competitor's research plan as well. So, the article suggested Indian institutes to focus on the latest emerging Anti-cancer technology trends, which are in practice by the international universities. Concurrently, this study may be a landmark indication for Indian public funded universities and institutes, calling for a U-turn from their traditional approaches.
该文章报道了对来自20所顶尖国际大学以及印度10家主要公共资助组织和研究机构的1708项抗癌专利进行的深入比较技术分析。该研究在药物发现、开发、诊断和治疗层面，将先锋大学与抗癌研究领域所使用的技术进行了区分，这些以新颖的实质专利格局图的形式呈现。所报道的竞争智能图确定遗传学、成分和合成化合物为主要技术；其次是天然提取物、联合用药和药物递送系统为新兴技术。外科器械、靶向治疗和动物模型的专利数量最少。此外，该研究分析了印度大学与国际大学相比所采用的关键技术，以确定印度公共资助机构忽视的技术。在这个瞬息万变的竞争世界中，每所大学制定自己的研究计划和重点领域至关重要；但与此同时，任何组织了解其竞争对手的研究计划也同样重要。因此，文章建议印度机构关注国际大学目前正在实践的最新抗癌技术趋势。同时，这项研究可能是印度公共资助大学和机构的一个标志性指示，呼吁它们从传统方法上做出转变。
